GLP/GMP-certified biological characterization for advanced biotherapeutics, quantifying functional efficacy and immunogenic impact with absolute precision.
A drug's clinical success is defined by its biological activity. At BrownBiology Laboratory, we provide high-resolution cell-based and potency assays that serve as the definitive benchmark for your therapeutic's performance.
Our specialized bioanalytical unit operates under strict GLP/GMP frameworks, utilizing advanced reporter gene systems, signal transduction mapping, and high-sensitivity neutralizing antibody (NAb) modules to quantify the true potency of small molecules, biologics, and viral vectors.
Consult Our Bioassay Strategists 鈫?/a>
Proving the biological truth of your molecules through validated cellular frameworks.
Quantifying the biological impact of therapeutics on cell growth and viability through optimized metabolic and fluorometric modules.
Mapping the intracellular response to drug binding, including second messenger quantification and reporter gene expression analysis.
Specialized GLP-certified assays detecting the presence of antibodies that interfere with the biological activity of therapeutic proteins.
Determining the relative biological activity of batches against reference standards, strictly following ICH and USP requirements.
Our cell-based bioassays are seamlessly integrated with our ligand-binding (ELISA, RIA, SPR) and structural analysis modules, providing a 360-degree view of your product stability, comparability, and release profiles.